Nov 5 (Reuters) - Iq3corp Ltd (IQ3) :
- ONCOTEX INC, IN WHICH CO HOLDS 40.5% STAKE, GOT LICENSING FOR A GOLD TECHNOLOGY FOR IMMUNE RESPONSE CANCER THERAPY
News: IQ3 Iq3corp Says Oncotex Got Licensing For A Gold Technology For Immune Response Cancer...
Add to My Watchlist
What is My Watchlist?